Larimar Therapeutics | Investor Presentation Deck | 32 slides · page 13 of 32
The slide uses a two-part structure to address clinical safety and non-clinical toxicology findings.
Pitch deck · traction · show_traction · overcrowded density
Slide locked Sign in to view
Slide schematic 7/7
callout 2/2 list 2/2 source-note 1/1 title 2/2
Components 7
primary primary bullet bullet source-note action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.